课题基金 / 基金详情

Maternal Omega-3 supplementation to reduce Bronchopulmonary Dysplasia in very Preterm Infants : A Randomized Controlled Trial (MOBYDIck Trial)

Maternal Omega-3 supplementation to reduce Bronchopulmonary Dysplasia in very Preterm Infants : A Randomized Controlled Trial (MOBYDIck Trial)
母亲补充 Omega-3 可减少早产儿的支气管肺发育不良：一项随机对照试验（MOBYDIck 试验）
批准号：
303685
负责人：
Marc Isabelle
金额：
$7.29万
依托单位：
Universit Laval
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-10-01 至 2014-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=303685&lang=en
关键词：
Breastfeeding Bronchopulmonary Dysplasia Child Neurodevelopment Neonatal Nutrition Omega-3 Fatty Acids Perinatality Prematurity Randomized Controlled Trial

项目摘要

项目成果

Marc Isabelle的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Every year in Canada, 1500 babies who are born early (prematurely) develop a serious lung disease called bronchopulmonary dysplasia (BPD). BPD causes major health problems in these infants, especially in their early childhood. In most situations, breast-m
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Maternal Omega-3 supplementation to reduce Bronchopulmonary Dysplasia in very Preterm Infants : A Randomized Controlled Trial (MOBYDIck Trial)
  • 批准号：
    304955
  • 项目类别：
    Operating Grants
  • 资助金额：
    $191.36万
  • 财政年份：
    2014
  • 负责人：
    Marc Isabelle
  • 依托单位：
    Universit Laval
海外基金